EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study

Tatsunori Toida, Noriaki Kurita, Masanori Abe, Norio Hanafusa, Nobuhiko Joki

Cardiorenal Medicine · 2024

DOI: 10.1159/000536595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Tatsunori Toida und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Magnesium, Renal Dialysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The dose-response relationship between serum magnesium (sMg) and atrial fibrillation (AF) and the contribution of dysmagnesemia to AF among hemodialysis patients remain unknown. Hence, we examined the dose-response correlation between sMg and AF and estimated the extent of the contribution of dysmagnesemia to AF in this population.

Methods

This was a nationwide cross-sectional study on the Japanese Society for Dialysis Therapy registry, also known as Japanese Renal Data Registry (JRDR), encompassing a nationwide population of dialysis centers, as of the end of 2019. Eligible participants were adult patients undergoing hemodialysis three times per week. The main exposure was sMg, categorized into seven categories (≤1.5, >1.5–≤2, >2–≤2.5, >2.5–≤3, >3–≤3.5, >3.5–≤4, and ≥4.0 mg/dL). The outcome was AF reported by dialysis facilities. The independent contribution to AF was assessed via logistic regression to generate population-attributable fractions, assuming a causal relationship between sMg and AF.

Results

Total 165,926 patients from 2,549 facilities were investigated. AF prevalence was 7.9%. Compared with the reference (>2.5–≤3 mg/dL), lower sMg was associated with increased AF (adjusted odds ratios [ORs] [95% confidence interval, CI] of 1.49 [1.19–1.85], 1.24 [1.17–1.32], and 1.11 [1.06–1.16] for sMg of ≤1.5, >1.5–≤2.0, and >2.0–≤2.5 mg/dL categories, respectively). Elevated sMg was associated with fewer AF (adjusted OR 0.87 [95% CI, 0.79–0.96] for sMg of >3.0–≤3.5 mg/dL). The adjusted population-attributable fraction of lower sMg and higher and lower sMg for AF was 7.4% and 6.9%, respectively. An association did indeed exist between lower sMg and AF, with the lowest percentages of AF at sMg levels above the reference range for the general population.

Conclusion

Dysmagnesemia may be an important contributor to AF among adult hemodialysis patients. Further longitudinal studies are warranted to determine whether sMg correction reduces the AF incidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationMagnesiumRenal DialysisAgedFemaleHumansMaleMiddle AgedCross-Sectional StudiesJapanKidney Failure, ChronicPrevalenceRegistriesRisk Factors

Stichwörter der Autor:innen

Atrial fibrillationDysmagnesemiaHemodialysisSerum magnesium

Substanzen

Magnesium

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, Miyazaki, Japan.
  • Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan.
  • The Subcommittee of Statistical Analysis, The Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Divisions of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • The Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.

Zitieren

APA

Toida, T., Kurita, N., Abe, M., Hanafusa, N., & Joki, N. (2024). Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study. Cardiorenal Medicine. https://doi.org/10.1159/000536595

Vancouver

Toida T, Kurita N, Abe M, Hanafusa N, Joki N. Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study. Cardiorenal Medicine. 2024. doi:10.1159/000536595

BibTeX
@article{Toida2024,
  author = {Toida, Tatsunori and Kurita, Noriaki and Abe, Masanori and Hanafusa, Norio and Joki, Nobuhiko},
  title = {Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study},
  journal = {Cardiorenal Medicine},
  year = {2024},
  doi = {10.1159/000536595}
}
Kostenlos starten →